Why is Remus Pharma. falling/rising?

As of 17-Jun, Remus Pharmaceuticals Ltd is currently priced at 1,862.90, reflecting a decrease of 12.9 points or 0.69%. The stock has shown a significant decline over the past month, with a return of -15.62%, and it is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Although the stock is 4.18% away from its 52-week low, it has outperformed its sector by 1.18% today. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 76.47% against the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Remus Pharmaceuticals has underperformed compared to the benchmark Sensex, which has seen a slight decline of only 1.00% over the past week. The stock's year-to-date performance is particularly concerning, with a drop of 25.41%, while the Sensex has gained 5.11% during the same period. This stark contrast highlights the challenges faced by Remus Pharmaceuticals in the current market environment, contributing to its recent price decline.